Effect of Motor Cortex Versus Sacral Magnetic Stimulation in Multiple Sclerosis Patients With Urinary Tract Dysfunction
Effect of Motor Cortex Magnetic Stimulation Versus Sacral Magnetic Stimulation in Lower Urinary Tract Dysfunction in Multiple Sclerosis Patients
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
This work is intended to assess the effect of repetitive magnetic stimulation on the sacral roots versus repetitive magnetic stimulation on motor cortex in multiple sclerosis patients with the lower urinary tract dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Oct 2014
Shorter than P25 for not_applicable multiple-sclerosis
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
February 2, 2018
CompletedFirst Posted
Study publicly available on registry
February 15, 2018
CompletedFebruary 15, 2018
February 1, 2018
6 months
February 2, 2018
February 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change from baseline King's Health QoL questionnaire score after treatment
questionnaire evaluates the impact of lower urinary tract symptoms on patient's quality of life. High scores represent a worse quality of life, with no cut-off values.
1-7 days after treatment
Change from baseline Post-void residual urine after treatment
Measured by ultrasound It is the volume of urine left in the bladder at the completion of micturition Measured in milliliters (mL)
1-7 days after treatment
Change from baseline Maximum Cystometric Capacity (MCC) after treatment
Measured by urodynamic evaluation Measured in millimeters (mL) It is the volume at which the patient states that he/she can no longer delay micturition because of strong desire to void or urgency
1-7 days after treatment
Change from baseline Maximum Flow Rate (Qmax) after treatment
Measured by urodynamic evaluation Measured in milliliters per second (mL/sec) It is the maximum measured value of the flow rate
1-7 days after treatment
Change from baseline Detrusor pressure at maximum flow rate (Pdet @Qmax) after treatment
Measured by urodynamic evaluation Measured in centimeter water (cmH2O) It represents the effect of the active and/or passive forces generated by the detrusor muscle
1-7 days after treatment
Study Arms (2)
Sacral magnetic stimulation
ACTIVE COMPARATORTwenty trains of 50 stimuli at 5 Hz (train duration: 10 seconds) separated by a 40-second pause were delivered for a total of 1000 pulses, once a day for four consecutive days for two weeks, over sacral roots
Cortical magnetic stimulation
ACTIVE COMPARATORTwenty trains of 50 stimuli at 5 Hz (train duration: 10 seconds) separated by a 40-second pause were delivered for a total of 1000 pulses, once a day for four consecutive days for two weeks, over motor cortex
Interventions
Twenty trains of 50 stimuli at 5 Hz (train duration: 10 seconds) separated by a 40-second pause were delivered for a total of 1000 pulses, once a day for four consecutive days for two weeks
Eligibility Criteria
You may qualify if:
- Multiple Sclerosis patients (diagnosed by McDonald criteria 2010) with lower urinary tract dysfunction
- Adults more than 18 years
- Unresponsiveness to medical treatment
- Urodynamic diagnosis of detrusor overactivity and/or detrusor underactivity and/or detrusor-sphincter dyssynergia
You may not qualify if:
- Urinary tract infections
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
February 2, 2018
First Posted
February 15, 2018
Study Start
October 1, 2014
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
February 15, 2018
Record last verified: 2018-02